The promotion of autophagy by DHRSX involves the downregulation of AKT/mTOR phosphorylation and the upregulation of beclin-1, which are highly related to the antiapoptotic function and chemotherapy resistance of leukemia cells [40–42]. Here, DHRSX is linked to leukemia.